CARE assigns ‘BBB-’ rating to Neuland Laboratories’ long term bank facilities

07 Jul 2014 Evaluate

Credit rating agency, CARE has assigned ‘BBB-’ rating to Neuland Laboratories’ long term bank facilities worth Rs 187.84 crore. The rating agency has also assigned ‘A3’ rating to the company’s short term bank facilities.

The ratings assigned to the bank facilities of the company derive strength from the extensive experience of the promoters in the pharmaceutical industry, revival in the financial performance of the company marked by significant improvement in profitability margins, overall gearing and debt coverage indicators, moderate product mix with rise in the share of high-margin products, timely receipt of funds and improvement in the liquidity position of the company and strategic corporate reorganisation to focus on its core business of manufacturing active pharmaceutical ingredients (API).

Neuland Laboratories is a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract manufacturing services to customers located in 85 countries. Its manufacturing facilities are inspected and approved by the US FDA and other leading regulatory agencies.

 

Neuland Laboratories Share Price

13712.60 266.60 (1.98%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.